Life and Death Decisions in the CD95 System: Main Proand Anti-Apoptotic Modulators

Cover Page

Cite item

Abstract

Apoptosis is common to all multicellular organisms. Apoptosis can be triggered by the extrinsic (death receptor (DR)) or the intrinsic (mitochondrial) death pathways.CD95 (APO-1/Fas) is a prototypic member of the DR family. This review is focused on the mechanisms of CD95 (APO-1/Fas)-mediated apoptosis and the role in the apoptosisof the death effector domain (DED)-containing proteins: pro-apoptotic protein procaspase-8 and anti-apoptotic protein c-FLIP. Gaining insights into these processes willimprove our understanding of the pathogenesis of diseases such as cancer, autoimmunity and AIDS, and will open new approaches to rational treatment strategies.

Full Text

Introd uction : CD95 and CD95 signaling CD95 (also called APO-1; Fas; fas antigen; tumor necrosis factor receptor superfamily member 6, TN FRSF6 or apoptosis antigen 1, APT1) is a member of the death receptor (DR) family, a subfamily of the tumor necrosis factor receptor superfamily (1). All members of the DR family are characterized by a cytoplasmic region termed the Death Domain (DD) (2;3). DD are 80-100 amino acid long motifs involved in the transduction of the apoptotic signal. The DD belongs to the so-called ‘death domain-fold superfamily’. This superfamily comprises the death domain (DD), the death effector domain (DED), and the caspase recruitment domain (CARD). Each of these motifs interacts with other proteins through homotypic interactions. All members of the DD-fold superfamily are characterized by similar structures that comprise six or seven antiparallel amphipatic α-helices. Crosslinking of CD95 with its natural ligand, CD95L (CD178) (4), or with agonistic antibodies, such as anti-APO-1 (5), induces apoptosis in sensitive cells. The binding of CD95L or agonistic antibodies to CD95 leads to the formation of the receptor complex at the cellular membrane, which was named death-inducing signaling complex (DISC) (6). The DISC consists of oligomerized receptors, the DD-containing adaptor molecule FADD/MORT 1 (Fas-Associated Death Domain), procaspase-8 (FLICE , MACHα, Mch5), procaspase10, and the cellular FLICE -inhibitory proteins (c-FLIP) (Fig. 1) (7-9). The interactions between the molecules at the DISC are based on homotypic contacts. The DD of the receptor interacts with the DD of FADD, while the DED of FADD interacts with the N-terminal tandem DEDs of procaspases8, -10 and c-FLIP. As a result of DISC formation procaspase8 is activated at the DISC resulting in the formation of the active caspase-8. Caspase-8 cleaves and thereby activates downstream effector caspases-3, -6, and -7.
×

About the authors

Inna N Lavrik

Tumorimmunology Program German Cancer Research Center

Email: i.lavrik@dkfz-heidelberg.de
Division of Immunogenetics Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany

Peter H Krammer

Tumorimmunology Program German Cancer Research Center

Division of Immunogenetics Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany

References

  1. Krammer, P. H. (2000) Nature 407, 789-95
  2. Tartaglia, L. A., Ayres, T. M., Wong, G. H., and Goeddel, D. V. (1993) Cell 74, 845-853
  3. Weber, C. H. and Vincenz, C. (2001) Trends Biochem Sci 26, 475-81
  4. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993) Cell 75, 1169-78
  5. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., and Krammer, P. H. (1989) Science 245, 301-5
  6. Krammer, P. H., Arnold, R., and Lavrik, I. N. (2007) Nat.Rev.Immunol. 7, 532-542
  7. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O’Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996) Cell 85, 817-27
  8. Sprick, M., Rieser, E., Stahl, H., Grosse-Wilde, A., Weigand, M., and Walczak, H. (2002) Embo J 21, 4520-4530
  9. Scaffidi, C., Schmitz, I., Krammer, P. H., and Peter, M. E. (1999) J Biol Chem 274, 1541-8
  10. Salvesen, G. S. (2002) Cell Death Differ 9, 3-5
  11. Fuentes-Prior, P. and Salvesen, G. S. (2004) Biochem.J. 384, 201-232
  12. Nicholson, D. W. (1999) Cell Death and Differentiation 6, 1028-1042
  13. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H., and Peter, M. E. (1997) Embo J 16, 2794-804
  14. Scaffidi, C., Medema, J. P., Krammer, P. H., and Peter, M. E. (1997) J Biol Chem 272, 26953-8
  15. Salvesen, G. S. and Dixit, V. M. (1999) Proc Natl Acad Sci U S A 96, 10964-7
  16. Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J. E., Edris, W. A., Sutherlin, D. P., Green, D. R., and Salvesen, G. S. (2003) Mol Cell 11, 529-41
  17. Chang, D. W., Xing, Z., Capacio, V. L., Peter, M. E., and Yang, X. (2003) Embo J 22, 4132-42
  18. Golks, A., Brenner, D., Schmitz, I., Watzl, C., Krueger, A., Krammer, P. H., and Lavrik, I. N. (2006) Cell Death.Differ. 13, 489-498
  19. Lavrik, I., Krueger, A., Schmitz, I., Baumann, S., Weyd, H., Krammer, P. H., and Kirchhoff, S. (2003) Cell Death Differ 10, 144-5
  20. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J. L., Schroter, M., Scaffidi, C., Krammer, P. H., Peter, M. E., and Tschopp, J. (1997) Nature 386, 517-21
  21. Budd, R. C., Yeh, W. C., and Tschopp, J. (2006) Nature Reviews Immunology 6, 196-204
  22. Krueger, A., Baumann, S., Krammer, P. H., and Kirchhoff, S. (2001) Mol Cell Biol 21, 8247-54
  23. Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., and Lavrik, I. N. (2005) J.Biol. Chem. 280, 14507-14513
  24. Golks, A., Brenner, D., Krammer, P. H., and Lavrik, I. N. (2006) Journal of Experimental Medicine 203, 1295-1305
  25. Chang, D. W., Xing, Z., Pan, Y., Algeciras-Schimnich, A., Barnhart, B. C., Yaish-Ohad, S., Peter, M. E., and Yang, X. (2002) Embo J 21, 3704-3714
  26. Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C., and Grutter, M. G. (2002) J Biol Chem 277, 45162-71
  27. Yeh, W. C., Itie, A., Elia, A. J., Ng, M., Shu, H. B., Wakeham, A., Mirtsos, C., Suzuki, N., Bonnard, M., Goeddel, D. V., and Mak, T. W. (2000) Immunity 12, 633-42

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009 Lavrik I.N., Krammer P.H.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies